positiveSYS.SOURCE: TechCrunch• 2026-11-10T20:47:05Z
Proximal Ventures Launches $27.5M Fund to Support AI-Driven Drug Development Startups
Proximal Ventures has raised $27.5 million for its debut fund to invest in startups leveraging AI for drug development, targeting automation of pharmaceutical services. The fund focuses on pre-seed and seed-stage companies developing AI-driven solutions to reduce costs and accelerate timelines in drug discovery and clinical trials.
Former SignalFire investor Sahir Raoof raises $27.5 million for new fund targeting AI in pharma.
*** END OF TRANSMISSION ***